# FDA Inspection 1120137 - Lupin Limited (Unit 1) - February 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-1/a9b297a8-9d6e-4c20-a713-08eee60dd4fb
Source feed: FDA_Inspections

> FDA Inspection 1120137 for Lupin Limited (Unit 1) on February 11, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120137
- Company Name: Lupin Limited (Unit 1)
- Inspection Date: 2020-02-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1245108 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-1/24931ce4-a622-40f3-b56c-5e531441fabb)
- [FDA Inspection 1245108 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-1/5de2e246-8c1f-4b40-bef7-fecd56de406a)
- [FDA Inspection 940157 - 2015-08-05](https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-1/d930f884-5991-4040-845a-fc8b9127e6fa)

Company: https://www.keypedia.com/companies/lupin-limited-unit-1/92edc845-1756-45db-9f08-e5d611078b5a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c